Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Browse Articles > Previous issues
10 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 32(2); April 2016
Prev issue Next issue
Editorials
Exposure to Cigarette Smoke Contributes to the Risk of Developing a Colorectal Adenoma, Doesn't It? Are Repeated Exposures to Such Smoke Dangerous?
Bong Hwa Lee, Min Jung Kim, Hyoung Chul Park
Ann Coloproctol. 2016;32(2):43-44.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.43
  • 2,790 View
  • 24 Download
PDF
Impact of Microsatellite Instability in Signet-Ring Cell and Mucinous Components in Patients With Colorectal Carcinoma
Ik Yong Kim
Ann Coloproctol. 2016;32(2):45-46.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.45
  • 2,963 View
  • 39 Download
  • 1 Web of Science
  • 2 Citations
PDF

Citations

Citations to this article as recorded by  
  • Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort
    Marion Allart, Florence Leroy, Stephano Kim, David Sefrioui, Mihane Nayeri, Aziz Zaanan, Benoit Rousseau, Meher Ben Abdelghani, Christelle de la Fouchardière, Wulfran Cacheux, Romain Legros, Samy Louafi, David Tougeron, Olivier Bouché, Nadim Fares, Guilla
    Digestive and Liver Disease.2022; 54(3): 391.     CrossRef
  • Cáncer de colon en Colombia, fenotipo molecular: tamizaje para síndromes con agregación familiar
    Mabel Elena Bohórquez L, Ángel Alexandro Criollo R, Luis Carvajal Carmona, María Magdalena Echeverry de Polanco
    Revista de la Asociación Colombiana de Ciencias Biológicas.2019; : 87.     CrossRef
Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer
Hyung Jin Kim, Seong Taek Oh
Ann Coloproctol. 2016;32(2):47-48.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.47
  • 2,682 View
  • 29 Download
PDF
Role of Permacol Injection in the Treatment of Patients With Fecal Incontinence
Doo Han Lee
Ann Coloproctol. 2016;32(2):49-50.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.49
  • 3,203 View
  • 50 Download
  • 3 Web of Science
  • 2 Citations
PDF

Citations

Citations to this article as recorded by  
  • Effectiveness of Autologous Fat Graft in Treating Fecal Incontinence
    Hyeonseok Jeong, Sung Hwan Hwang, Hyoung Rae Kim, Kil O Ryu, Jiyong Lim, Hye Mi Yu, Jihoon Yoon, Chee Young Kim, Kwang-Yong Jeong, Young Jae Jung, In Seob Jeong, Young Gil Choi
    Annals of Coloproctology.2019; 35(3): 144.     CrossRef
  • Sacral neuromodulation compared with injection of bulking agents for faecal incontinence following obstetric anal sphincter injury – a randomized controlled trial
    M. Rydningen, T. Dehli, T. Wilsgaard, A. Rydning, M. Kumle, R. O. Lindsetmo, S. Norderval
    Colorectal Disease.2017;[Epub]     CrossRef
Original Articles
Association Between Exposure to Environmental Tobacco Smoke at the Workplace and Risk for Developing a Colorectal Adenoma: A Cross-Sectional Study
Seung-Hwa Lee, Ji-Yeon Hong, Jung-Un Lee, Dong Ryul Lee
Ann Coloproctol. 2016;32(2):51-57.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.51
  • 3,778 View
  • 37 Download
  • 4 Web of Science
  • 5 Citations
AbstractAbstract PDF
Purpose

A colorectal adenoma (CRA) is a well-defined precursor to colorectal cancer (CRC). Additionally, smoking is a potent risk factor for developing a CRA, as well as CRC. However, the association between exposure to environmental tobacco smoke (ETS) and the risk for developing a CRA has not yet been fully evaluated in epidemiologic studies. We performed a cross-sectional analysis on the association between exposure to ETS at the workplace and the risk for developing a CRA.

Methods

The study was conducted on subjects who had undergone a colonoscopy at a health promotion center from January 2012 to December 2012. After descriptive analyses, overall and subgroup analyses by smoking status were performed by using a multivariate logistic regression.

Results

Among the 1,129 participants, 300 (26.6%) were diagnosed as having CRAs. Exposure to ETS was found to be associated with CRAs in all subjects (fully adjusted odds ratio [OR], 1.95; 95% confidence interval [CI], 1.08–2.44; P = 0.001). In the subgroup analysis, exposure to ETS in former smokers increased the risk for developing a CRA (fully adjusted OR, 4.44; 95% CI, 2.07–9.51; P < 0.001).

Conclusion

Exposure to occupational ETS at the workplace, independent of the other factors, was associated with increased risk for developing a CRA in all subjects and in former smokers. Further retrospective studies with large sample sizes may be necessary to clarify the causal effect of this relationship.

Citations

Citations to this article as recorded by  
  • Epidemiological and clinicopathological characteristics of colorectal cancer patients in tertiary hospital in West Java
    Kiki Lukman, Arrayyan Muhammad, Mohammad Ghozali, Prapanca Nugraha, Yunia Sribudiani, Bistamy Muhammad Nursabur
    Clinical Epidemiology and Global Health.2024; 28: 101688.     CrossRef
  • RISK FACTORS OF COLORECTAL CANCER IN SULAIMANI CITY
    Mohammed Hassan, Kameran Ismail, Zhian Ramzi, Tariq Al-Hadithi
    JOURNAL OF SULAIMANI MEDICAL COLLEGE.2018; 8(1): 47.     CrossRef
  • Plausible Roles for RAGE in Conditions Exacerbated by Direct and Indirect (Secondhand) Smoke Exposure
    Joshua Lewis, Kelsey Hirschi, Juan Arroyo, Benjamin Bikman, David Kooyman, Paul Reynolds
    International Journal of Molecular Sciences.2017; 18(3): 652.     CrossRef
  • Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis
    Yi-Chao Hou, Qiang Hu, Jiao Huang, Jing-Yuan Fang, Hua Xiong
    Oncotarget.2017; 8(5): 8843.     CrossRef
  • Exposure to Cigarette Smoke Contributes to the Risk of Developing a Colorectal Adenoma, Doesn't It? Are Repeated Exposures to Such Smoke Dangerous?
    Bong Hwa Lee, Min Jung Kim, Hyoung Chul Park
    Annals of Coloproctology.2016; 32(2): 43.     CrossRef
Prognostic Impact of Microsatellite Instability in Colorectal Cancer Presenting With Mucinous, Signet-Ring, and Poorly Differentiated Cells
Sang Hun Jung, So Hyun Kim, Jae Hwang Kim
Ann Coloproctol. 2016;32(2):58-65.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.58
  • 4,173 View
  • 56 Download
  • 14 Web of Science
  • 16 Citations
AbstractAbstract PDF
Purpose

Mucinous cells (MUCs), signet-ring cells (SRCs), and poorly differentiated cells (PDCs) are uncommon histologic types and have been associated with advanced tumor stage and poor prognosis. However, MUCs, SRCs, and PDCs are commonly observed in cancers with high microsatellite instability (MSI), which have favorable outcomes compared with cancers with microsatellite stability (MSS). The purpose of this study was to evaluate the prognostic impact of high-MSI in patients with sporadic colorectal cancer presenting with MUCs, SRCs, and/or PDCs.

Methods

Between January 2006 and December 2012, 176 with proven microsatellite status who also presented with MUCs, SRCs, and PDCs were selected for this study and were divided into 2 groups, high-MSI and MSS; their outcomes were analyzed.

Results

Of the 176 patients, 56 and 120, respectively, had high-MSI and MSS cancers. High-MSI cancers had larger tumors, proximal tumor location, and a lower TNM stage. The recurrence rate was lower in the high-MSI group (13.7% vs. 35.4%, P = 0.006). Common patterns of distant metastasis for MUC, SRC, PDC cancers were peritoneal spread (46.9%) and hematogenous metastasis (46.4%). The 5-year CSS rates were 88.2% and 61.2% for patients with high-MSI and MSS cancers, respectively (P < 0.0001). In the multivariate analysis, except for stage-IV cancer, MSI status was an independent risk factor for cancer-specific survival (MSS: hazard ratio, 4.34; 95% confidence interval, 1.68-11.21).

Conclusion

In patients with colorectal cancer presenting with MUCs, SRCs, and/or PDCs, those with high-MSI cancers had better outcomes.

Citations

Citations to this article as recorded by  
  • Clinicopathological features and evaluation of microsatellite stability of colorectal carcinoma with cribriform comedo pattern
    Tuğba Günler, Pinar Karabağli, Hicret Tiyek, Özge Keskin, Muslu K. Körez
    Indian Journal of Pathology and Microbiology.2024; 67(2): 275.     CrossRef
  • Correlation of clinical, pathologic, and genetic parameters with intratumoral immune milieu in mucinous adenocarcinoma of the colon
    Azfar Neyaz, Amaya Pankaj, Andrew Crabbe, Steffen Rickelt, Lieve Leijssen, Anne Dinaux, Martin Taylor, Stuti G. Shroff, Rory Crotty, M. Lisa Zhang, Omer H. Yilmaz, Osman Yılmaz, Deepa T. Patil, Aparna R. Parikh, David T. Ting, David Berger, Vikram Deshpan
    Modern Pathology.2022; 35(11): 1723.     CrossRef
  • The Molecular Associations of Signet-Ring Cell Carcinoma in Colorectum: Meta-Analysis and System Review
    Xueting Liu, Litao Huang, Menghan Liu, Zhu Wang
    Medicina.2022; 58(7): 836.     CrossRef
  • Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis
    James W. T. Toh, Kevin Phan, Faizur Reza, Pierre Chapuis, Kevin J. Spring
    International Journal of Colorectal Disease.2021; 36(8): 1573.     CrossRef
  • Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation
    David S. Williams, Dmitri Mouradov, Marsali R. Newman, Elham Amini, David K. Nickless, Catherine G. Fang, Michelle Palmieri, Anuratha Sakthianandeswaren, Shan Li, Robyn L. Ward, Nicholas J. Hawkins, Iain Skinner, Ian Jones, Peter Gibbs, Oliver M. Sieber
    Modern Pathology.2020; 33(7): 1420.     CrossRef
  • Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis
    Dongjun Dai, Yanmei Wang, Liyuan Zhu, Hongchuan Jin, Xian Wang
    PeerJ.2020; 8: e9149.     CrossRef
  • Implication of Microsatellite Instability in Chinese Cohort of Human Cancers


    Meiying Cui, Pan Li, Ying Mao, Lan Zhang, Peiyi Xia, Enjie Liu, Weiwei Wang, Jianying Zhang, Guozhong Jiang, Wencai Li
    Cancer Management and Research.2020; Volume 12: 10287.     CrossRef
  • Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry
    Li Chia Chong, Amanda Rose Townsend, Joanne Young, Amitesh Roy, Cynthia Piantadosi, Jennifer E. Hardingham, David Roder, Christos Karapetis, Robert Padbury, Guy Maddern, James Moore, Timothy Jay Price
    Targeted Oncology.2019; 14(1): 85.     CrossRef
  • Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma
    Krittiya Korphaisarn, Van Morris, Jenifer S. Davis, Michael J. Overman, David R. Fogelman, Bryan K. Kee, Arvind Dasari, Kanwal P. S. Raghav, Imad Shureiqi, Metha Trupti, Robert A. Wolff, Cathy Eng, David G. Menter, Stanley Hamilton, Scott Kopetz
    British Journal of Cancer.2019; 121(6): 505.     CrossRef
  • SILAC-Based Quantification of TGFBR2-Regulated Protein Expression in Extracellular Vesicles of Microsatellite Unstable Colorectal Cancers
    Fabia Fricke, Malwina Michalak, Uwe Warnken, Ingrid Hausser, Martina Schnölzer, Jürgen Kopitz, Johannes Gebert
    International Journal of Molecular Sciences.2019; 20(17): 4162.     CrossRef
  • Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis
    Bingyan Wang, Fei Li, Xin Zhou, Yanpeng Ma, Wei Fu
    World Journal of Surgical Oncology.2019;[Epub]     CrossRef
  • Cáncer de colon en Colombia, fenotipo molecular: tamizaje para síndromes con agregación familiar
    Mabel Elena Bohórquez L, Ángel Alexandro Criollo R, Luis Carvajal Carmona, María Magdalena Echeverry de Polanco
    Revista de la Asociación Colombiana de Ciencias Biológicas.2019; : 87.     CrossRef
  • Evaluation of Long-Term Outcomes of Microsatellite Instability Status in an Asian Cohort of Sporadic Colorectal Cancers
    Winson Jianhong Tan, Julie Liana Hamzah, Sanchalika Acharyya, Fung Joon Foo, Kiat Hon Lim, Iain Bee Huat Tan, Choong Leong Tang, Min Hoe Chew
    Journal of Gastrointestinal Cancer.2018; 49(3): 311.     CrossRef
  • What are the Clinicopathological Features and Outcomes of Sporadic Colorectal Cancer (CRC) in an Ethiopian Cohort with focus on young-onset CRC?
    Dominic Worku
    Journal of Cancer Prevention & Current Research.2017;[Epub]     CrossRef
  • Mismatch Repair Proteins and Microsatellite Instability in Colorectal Carcinoma (MLH1, MSH2, MSH6 and PMS2): Histopathological and Immunohistochemical Study
    Nour El Hoda S. Ismael, Samar A. El Sheikh, Suzan M. Talaat, Eman M. Salem
    Open Access Macedonian Journal of Medical Sciences.2017; 5(1): 9.     CrossRef
  • Impact of Microsatellite Instability in Signet-Ring Cell and Mucinous Components in Patients With Colorectal Carcinoma
    Ik Yong Kim
    Annals of Coloproctology.2016; 32(2): 45.     CrossRef
Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer
Sunmi Jo, Yunseon Choi, Sung-Kwang Park, Jin-Young Kim, Hyun Jung Kim, Yun-Han Lee, Won Yong Oh, Heunglae Cho, Ki Jung Ahn
Ann Coloproctol. 2016;32(2):66-72.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.66
  • 3,919 View
  • 36 Download
  • 8 Web of Science
  • 7 Citations
AbstractAbstract PDF
Purpose

This study aimed to evaluate the effects of radiotherapy (RT) on progression-free survival (PFS) for patients with recurrent colorectal cancer.

Methods

We reviewed the records of 22 patients with recurrent colorectal cancer treated with RT between 2008 and 2014. The median radiation dose for recurrent disease was 57.6 Gy (range, 45–75.6 Gy). Patients were divided into 2 groups according to the type of RT: patients underwent RT without previous history of irradiation (n = 14) and those treated with secondary RT (reirradiation: n = 8) at the time of recurrence.

Results

The median follow-up period was 24.9 months (range, 4.5–66.6 months). Progression was observed in 14 patients (including 8 with loco-regional failure and 9 with distant metastases). Distant metastases were related to the RT dose (<70 Gy, P = 0.031). The 2-year loco-regional control (LRC), PFS, and overall survival (OS) rates were 74.6%, 45.1%, and 82.0%, respectively. The LRC rate was not different between the patients treated with RT for the first time and those treated with reirradiation (P = 0.101, 2-year LRC 79.5% vs. 41.7%). However, reirradiation was related to poor PFS (P = 0.022) and OS (P = 0.002). An escalated RT dose (≥70 Gy) was associated with a higher PFS (P = 0.014, 2-year PFS 63.5% vs. 20.8%).

Conclusion

Salvage RT for locally recurrent colorectal cancer can be offered when surgery is impossible. Dose-escalated RT shows a possible benefit in reducing the risk of progression.

Citations

Citations to this article as recorded by  
  • Carbon-ion Radiotherapy for Colorectal Cancer
    Shigeru Yamada, Hirotoshi Takiyama, Yuka Isozaki, Makoto Shinoto, Hirokazu Makishima, Naoyoshi Yamamoto, Hiroshi Tsuji
    Journal of the Anus, Rectum and Colon.2021; 5(2): 113.     CrossRef
  • LncRNA TTN‐AS1/miR‐134‐5p/PAK3 axis regulates the radiosensitivity of human large intestine cancer cells through the P21 pathway and AKT/GSK‐3β/β‐catenin pathway
    Zhenkui Zuo, Shuling Ji, Lulu He, Yage Zhang, Zining Peng, Jiarui Han
    Cell Biology International.2020; 44(11): 2284.     CrossRef
  • A Review on the Special Radiotherapy Techniques of Colorectal Cancer
    Shing Yau Tam, Vincent W. C. Wu
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Comparison of overall survival and quality of life between patients undergoing anal reconstruction and patients undergoing traditional lower abdominal stoma after radical resection
    P. Du, S.-Y. Wang, P.-F. Zheng, J. Mao, H. Hu, Z.-B. Cheng
    Clinical and Translational Oncology.2019; 21(10): 1390.     CrossRef
  • Prospective Observational Study of High-Dose Carbon-Ion Radiotherapy for Pelvic Recurrence of Rectal Cancer (GUNMA 0801)
    Shintaro Shiba, Masahiko Okamoto, Hiroki Kiyohara, Tatsuya Ohno, Takuya Kaminuma, Takayuki Asao, Hitoshi Ojima, Ken Shirabe, Hiroyuki Kuwano, Takashi Nakano
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Effects of varying radiation dosages on MMP1 expression, and MMP1 knockdown on the viability and migration of SW620 cells
    Fang Ju, Na Li, Wenming Wang, Haicheng Yuan
    Molecular Medicine Reports.2019;[Epub]     CrossRef
  • Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer
    Hyung Jin Kim, Seong Taek Oh
    Annals of Coloproctology.2016; 32(2): 47.     CrossRef
Safety and Efficacy of Permacol Injection in the Treatment of Fecal Incontinence
Yahya A Al-Abed, Jennifer Ayers, Abraham Ayantunde, Bandipalyam V Praveen
Ann Coloproctol. 2016;32(2):73-78.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.73
  • 4,325 View
  • 41 Download
  • 4 Web of Science
  • 4 Citations
AbstractAbstract PDF
Purpose

Permacol has been gaining popularity in recent times for the treatment of fecal incontinence (FI). This study aims to evaluate the safety and efficacy of anal submucosal Permacol injection in the treatment of FI.

Methods

All consecutive patients who underwent Permacol injection for FI over a 3-year period were included. Patients' data relating to obstetric history, anorectal/pelvic operations, type of FI, preoperative anorectal physiology results and follow-up details for outcome measures were collected. Preoperative and postoperative Cleveland Clinic Florida Incontinence Scores (CCFISs) were noted. Patients were surveyed by using a telephone questionnaire to assess the quality of life and other outcome measures. Data were analysed using SPSS ver.19.0.

Results

Thirty patients (28 females and 2 males) with a median age of 67 years were included in the study. Of those patients, 37%, 50%, and 13% were noted to have passive, mixed and urge FI, respectively. Six of the patients (20%) had repeat Permacol injections, 5 of whom had sustained responses to the first Permacol injection for a mean of 11 months. There was a significant improvement in the CCFIS from a baseline median of 12.5, mean 12.8 interquartile range [IQR], 6–20), to a median of 3.5, mean 4.8 (IQR, 0–20), P < 0.001. Of the patients surveyed by telephone 89% were satisfied with their overall experience and the improvement in their symptoms following Permacol injections.

Conclusion

This study has demonstrated that Permacol injection for the treatment of FI is safe and effective and has no associated major complications. However, the results are not permanent; consequently, a significant proportion of the patients with an initial response may require repeat injections.

Citations

Citations to this article as recorded by  
  • Effectiveness of Autologous Fat Graft in Treating Fecal Incontinence
    Hyeonseok Jeong, Sung Hwan Hwang, Hyoung Rae Kim, Kil O Ryu, Jiyong Lim, Hye Mi Yu, Jihoon Yoon, Chee Young Kim, Kwang-Yong Jeong, Young Jae Jung, In Seob Jeong, Young Gil Choi
    Annals of Coloproctology.2019; 35(3): 144.     CrossRef
  • Functional Outcome of Human Adipose Stem Cell Injections in Rat Anal Sphincter Acute Injury Model
    Kirsi Kuismanen, Miia Juntunen, Nathaniel Narra Girish, Heikki Tuominen, Heini Huhtala, Kari Nieminen, Jari Hyttinen, Susanna Miettinen
    Stem Cells Translational Medicine.2018; 7(3): 295.     CrossRef
  • Sacral neuromodulation compared with injection of bulking agents for faecal incontinence following obstetric anal sphincter injury – a randomized controlled trial
    M. Rydningen, T. Dehli, T. Wilsgaard, A. Rydning, M. Kumle, R. O. Lindsetmo, S. Norderval
    Colorectal Disease.2017;[Epub]     CrossRef
  • Role of Permacol Injection in the Treatment of Patients With Fecal Incontinence
    Doo Han Lee
    Annals of Coloproctology.2016; 32(2): 49.     CrossRef
Case Reports
Incidentally Solitary, Synchronous, Metastatic Left Adrenal Mass From Colon Cancer
Mina Alvandipour, Mohammad Yasin Karami, Mehdi Khalvati, Hamed Khodabakhsh
Ann Coloproctol. 2016;32(2):79-82.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.79
  • 5,317 View
  • 47 Download
  • 2 Web of Science
  • 4 Citations
AbstractAbstract PDF

The authors report the case of a 63-year-old man who underwent an open adrenalectomy for a synchronous, malignant, metastatic left adrenal tumor and a total colectomy for T3N0M1 (stage 4) primary, malignant colon cancer. Two polypoid lesions, one measuring 40 mm × 30 mm × 30 mm and the other measuring 20 mm × 10 mm × 10 mm, were found in the ascending colon and rectosigmoid (RS) junction, respectively, and a synchronous, malignant, left adrenal gland lesion measuring 70 mm × 50 mm × 30 mm was incidentally found on abdominal computed tomography scan. Histological examination revealed a metastatic, necrotic adenocarcinoma of the left adrenal mass, an adenocarcinoma of the cecal mass, and an adenomatous polyp (tubulovillous type) of the smallest polypoid lesion in RS junction that had invaded deeply into the submucosal layer. The patient recovered uneventfully, and his condition is now stable, with no evidence of local recurrence or metastatic disease, 2 years after the surgery. To the best of our knowledge, only 25 cases of an adrenalectomy for treating metastatic adrenal gland tumors have been reported to date; physicians should be aware of the possibility of this event.

Citations

Citations to this article as recorded by  
  • Surgical resection of adrenal metastasis from colorectal cancers: a systematic review
    Thi Ai Van Terresa Nguyen, Sze Ling Wong, Zi Qin Ng
    ANZ Journal of Surgery.2024; 94(4): 545.     CrossRef
  • An Adrenal Incidentaloma After Colon/Rectal Cancer Surgery: A Primer Lesion or Metastasis—A Case Report
    Adalet Daş, İbrahim Ethem Cakcak, Derya Karabulut, Dicle Tamer Türk
    SN Comprehensive Clinical Medicine.2024;[Epub]     CrossRef
  • Solitary metastasis of colorectal cancer in the left adrenal gland 4 years after surgery on the primary tumor. Case report
    Marina D. Budurova, Vladimir S. Trifanov, Vladimir V. Kopylov, Olga S. Kuznetsova, Maria A. Chernichenko, Sergey I. Poluektov
    Journal of Modern Oncology.2023; 25(3): 401.     CrossRef
  • Synchronous contralateral adrenal metastasis of colorectal cancer: case report
    Micaela Raices, Luis Boccalatte, Gustavo Rossi, Fernando Wright
    Journal of Surgical Case Reports.2017;[Epub]     CrossRef
Xanthogranulomatous Appendicitis Mimicking Residual Burkitt's Lymphoma After Chemotherapy
Soomin Nam, Jeonghyun Kang, Sung-Eun Choi, Yu Ri Kim, Seung Hyuk Baik, Seung-Kook Sohn
Ann Coloproctol. 2016;32(2):83-86.   Published online April 30, 2016
DOI: https://doi.org/10.3393/ac.2016.32.2.83
  • 3,560 View
  • 43 Download
  • 4 Web of Science
  • 8 Citations
AbstractAbstract PDF

The case of a 23-year-old female treated with aggressive high-dose therapy for Burkitt's lymphoma is reported. A positron emission tomography and computed tomography scan after completion of chemotherapy revealed a residual hypermetabolic lesion in the right pelvic cavity. A pelvic magnetic resonance imaging scan showed circumferential wall thickening at the tip of the appendix. A laparoscopic exploration and appendectomy were performed, and a pathologic examination of the resected appendix revealed xanthogranulomatous appendicitis. This is a rare case of a xanthogranulomatous appendicitis mimicking remnant Burkitt's lymphoma after completion of chemotherapy.

Citations

Citations to this article as recorded by  
  • Xanthogranulomatous appendicitis presenting asymptomatically 3 years after surgery for hilar cholangiocarcinoma: A case report
    Nobuhisa Tanioka, Michio Kuwahara, Takashi Sakai, Yuzuko Nokubo, Makoto Hiroi, Toyokazu Akimori
    International Journal of Surgery Case Reports.2024; 120: 109800.     CrossRef
  • A case of xanthogranulomatous appendicitis that was difficult to diagnose
    Yusaku WATANABE, Shingo SHIOYA, Tetsuhito ARIKIZONO, Syuzou TASHIMA, Toshiyuki CHOSA, Hiroshi SUGITA, Kyouko MIZUKAMI, Kentaro TOKUDOME, Kaoru HIJIKURO, Kouichirou SHIGETA
    Choonpa Igaku.2023; 50(2): 121.     CrossRef
  • Focal Xanthogranulomatous Pyelonephritis on FDG PET/CT
    Yong Liu, Guansheng Tong, Zhe Wen
    Clinical Nuclear Medicine.2022; 47(9): e611.     CrossRef
  • Xanthogranulomatous appendicitis misdiagnosed as a malignant tumor: A case report
    Subo Wang, Tingchong Jiang, Xiaoxuan Zhou, Xiaoming Mao
    Asian Journal of Surgery.2022; 45(8): 1650.     CrossRef
  • A Case of Laparoscopic Cecectomy for Xanthogranulomatous Appendicitis
    Marina ISOKAWA, Aya SATO, Ken IMAIZUMI, Kentaro SATO, Hiroyuki KASAJIMA, Hanae KUSHIBIKI, Norihiko SHIMOYAMA, Kazuaki NAKANISHI
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2022; 83(11): 1948.     CrossRef
  • Xanthogranulomatous appendicitis: A comprehensive literature review
    Sami Akbulut, Khaled Demyati, Cemalettin Koc, Adem Tuncer, Emrah Sahin, Mehmet Ozcan, Emine Samdanci
    World Journal of Gastrointestinal Surgery.2021; 13(1): 76.     CrossRef
  • A Case of Xanthogranulomatous Appendicitis That Was Difficult to Differentiate from Appendiceal Mucocele
    Hirofumi Doi, Kazuhiro Toyota, Satoshi Hirahara, Yuta Kuhara, Kenji Shirakawa, Tetsuhiro Hara, Hironori Kobayashi, Yoshihiro Sakashita, Motoki Ninomiya, Fumio Shimamoto, Katsunari Miyamoto
    The Japanese Journal of Gastroenterological Surgery.2021; 54(3): 208.     CrossRef
  • A Case of Xanthogranulomatous Appendicitis
    Shoichiro NAKAJO, HoMin KIM, Ryoji NONAKA, Jun KAJIHARA, Masami IMAKITA, Toshikazu ITO, Masahiro TANEMURA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2019; 80(12): 2233.     CrossRef

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP